Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0FU2V
|
||||
Former ID |
DNC010077
|
||||
Drug Name |
D-237
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529836] | ||
Structure |
Download2D MOL |
||||
Formula |
C25H35N3O
|
||||
Canonical SMILES |
CCCN(CCN1CCN(CC1)C2=CC=CC=C2)C3CCC4=C(C3)C=CC=C4O
|
||||
InChI |
1S/C25H35N3O/c1-2-13-27(23-11-12-24-21(20-23)7-6-10-25(24)29)17-14-26-15-18-28(19-16-26)22-8-4-3-5-9-22/h3-10,23,29H,2,11-20H2,1H3/t23-/m0/s1
|
||||
InChIKey |
ACDYFMOSSUKHJD-QHCPKHFHSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | D(2) dopamine receptor | Target Info | Inhibitor | [529836] | |
D(3) dopamine receptor | Target Info | Inhibitor | [529836] | ||
WikiPathways | Hypothetical Network for Drug Addiction | ||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
Genes and (Common) Pathways Underlying Drug Addiction | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
Nicotine Activity on Dopaminergic NeuronsWP58:Monoamine GPCRs | |||||
Nicotine Activity on Dopaminergic Neurons | |||||
GPCRs, Other | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.